Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
158.72B
Market cap158.72B
Price-Earnings ratio
25.83
Price-Earnings ratio25.83
Dividend yield
2.59%
Dividend yield2.59%
Average volume
14.53M
Average volume14.53M
High today
$92.65
High today$92.65
Low today
$91.06
Low today$91.06
Open price
$92.15
Open price$92.15
Volume
12.80M
Volume12.80M
52 Week high
$139.06
52 Week high$139.06
52 Week low
$90.72
52 Week low$90.72

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $91.49. The company's market cap stands at 158.72B, with a P/E ratio of 25.83 and a dividend yield of 2.6%.

On 2026-04-25, Abbott(ABT) stock moved within a range of $91.06 to $92.65. With shares now at $91.49, the stock is trading +0.5% above its intraday low and -1.2% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 12.8M, versus its average volume of 14.53M.

The stock's 52-week range extends from a low of $90.72 to a high of $139.06.

The stock's 52-week range extends from a low of $90.72 to a high of $139.06.

ABT News

Simply Wall St 2d
Abbott CancerGuard Data And AACR Award Add To Oncology Growth Story

Abbott Laboratories (NYSE:ABT) received an AACR award for multi year outcomes from the DETECT A trial using its Cancerguard multi cancer early detection test....

Abbott CancerGuard Data And AACR Award Add To Oncology Growth Story
TipRanks 4d
Abbott downgraded to Neutral from Outperform at Daiwa

Daiwa downgraded Abbott (ABT) to Neutral from Outperform with a price target of $92, down from $113. Unlock hedge fund-level data and powerful investing tools...

Simply Wall St 5d
How Investors May Respond To Abbott Cancerguard Data Amid Legal And Earnings Pressures

Earlier in April 2026, Abbott Laboratories reported first-quarter sales of US$11.16 billion but lower net income of US$1.08 billion, while also facing a US$70 m...

How Investors May Respond To Abbott Cancerguard Data Amid Legal And Earnings Pressures

Analyst ratings

75%

of 32 ratings
Buy
75%
Hold
25%
Sell
0%

More ABT News

Nasdaq 5d
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom

Key Points Abbott Laboratories and Dexcom are the biggest players in the market for continuous glucose monitoring devices. Abbott has a vast lineup of product...

Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom
The Motley Fool 5d
Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount

The stock market has been a volatile place over the past few months, with the S&P 500 shifting from gains to losses. The market didn't exactly crash, but at cer...

Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount
Simply Wall St 6d
Assessing Abbott Laboratories Valuation After Recent Share Price Weakness

Advertisement Why Abbott Laboratories (ABT) is on investors’ radar Abbott Laboratories (ABT) is drawing attention after a period of weaker share performance,...

Assessing Abbott Laboratories Valuation After Recent Share Price Weakness

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.